The Drug Enforcement Administration (DEA) issued an advisory on Tuesday to notify the public about an initial hearing on the ...

DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies. Debate ...

DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal ...

HHS has declined a request from the DEA to provide witnesses to an upcoming hearing on the Biden Administration's proposal to ...

The proposal is to move marijuana from a Schedule I drug, along with heroin and LSD, to Schedule III, where it would join ...

The DEA will hold hearings on whether to lessen restrictions on marijuana where it would be in the same class of drugs as ...

Nobody knows how a Schedule III designation will change cannabis policy across the board, but the Department of Veterans ...

Health and Human Services recommended that DEA reschedule marijuana to Schedule III in 2023. For decades, cannabis has been classified as a Schedule I drug, a class defined as drugs with no ...

(The Center Square) – The Drug Enforcement Administration plans to hold a formal hearing next week on its plan to reschedule marijuana at the federal level. The proposal is to move marijuana ...